Johnson & Johnson Stock Performance Outpaces Market Amid Strong Q1 Earnings
Johnson & Johnson (JNJ) has outperformed both the S&P 500 and healthcare sector benchmarks over the past year, with shares rising 47.1% in 52 weeks compared to a 6.2% gain for XLV. The company reported better-than-expected Q1 earnings on April 14, including sales growth of 9.9% YoY and an upward revision of its fiscal 2026 guidance.
Topics: healthcare sector Johnson & Johnson stock performance Wall Street analysts